WhiteSwell announced positive initial results from its DELTA-HF trial evaluating its eLym system for excess fluid removal. Galway, Ireland-based WhiteSwell designed eLym to treat acute decompensated heart failure (ADHF). It presented data at the Heart Failure Society of America (HFSA) Annual Scientific Meeting 2023 in Cleveland, Ohio. The study evaluates the eLym minimally invasive catheter-based […]
Catheters
Biosense Webster: Catheter ablation leads to lower heart failure risk in AFib patients
Johnson & Johnson’s Biosense Webster today announced data supporting the use of catheter ablation in AFib patients. The study, funded by the Irvine, California-based company, looked at heart failure incidence risks in AFib patients. It compared the use of catheter ablation versus antiarrhythmic drugs (AAD). Looking at non-specific catheter claims information, it showed catheter ablation’s […]
Pulse Biosciences, CardioNXT to collab on pulsed-field ablation trial
Pulse Biosciences (Nasdaq:PLSE) announced today that it entered into a collaboration with CardioNXT to support its AFib treatment. The collaboration supports Pulse Biosciences’ planned first-in-human study of its pulsed-field ablation technology. Hayward, California-based Pulse develops a proprietary nanosecond pulsed-field ablation (nsPFA) cardiac catheter to treat AFib. Pulse and CardioNXT plan for their partnership to integrate the […]
Cordis acquires drug-eluting balloon maker MedAlliance for up to $1.135B
MedAlliance announced today that Cordis acquired it for a total consideration that could reach up to $1.135 billion. The companies initially announced the planned deal in October of last year. Cordis, which develops interventional cardiovascular and endovascular technologies, made a $35 million investment last year. Its upfront closing payment totals $200 million, with achievement milestones […]
PercAssist treats first patient in heart failure support trial
PercAssist announced today that it successfully completed the first patient treatment in its EUREKA first-in-human clinical study. The study evaluates PercAssist’s minimally invasive extravascular platform that provides hemodynamic support for chronic heart failure patients. Principal investigator Dr. Petr Neuzil completed the first case at the Na Homolce Hospital in Prague, Czech Republic. Also involved were […]
Biosense Webster begins Omnypulse pulsed-field ablation trial
Johnson & Johnson’s Biosense Webster today announced the first cases with its investigational Omnypulse catheter as part of the Omny-IRE clinical trial. The Omnypulse platform features the Omnypulse catheter and the Trupulse generator. Omny-IRE looks at the platform for mapping and treatment of symptomatic paroxysmal AFib during standard ablation procedures. Dr. Dr. Mattias Duytschaever performed […]
Farapulse founder’s Field Medical raises $14M for next-gen cardiac ablation tech
Field Medical announced today that it closed an oversubscribed seed round with investments reaching $14 million. Private investors led the funding for the Cardiff-by-the-Sea, California-based cardiac ablation technology developer. Multiple strategic investors also joined the round. The company earmarked the funds to support preclinical-to-clinical development activities. That includes first-in-human studies slated to begin in early […]
Shockwave picks Abbott Vascular exec Dr. Nick West as next chief medical officer
Shockwave Medical announced today that it appointed Dr. Nick West as its new associate chief medical officer. West’s appointment marks the start of an eventual transition. He reports to the current CMO, Dr. Keith Dawkins, with intentions to succeed Dawkins in mid-2024. “Dr. West brings to Shockwave a wealth of expertise in the interventional cardiology […]
Gradient Denervation raises $15M Series A for catheter tech
Gradient Denervation Technologies announced that it closed a $15 million (€14 million) Series A financing round. Paris-based Gradient develops a catheter-based solution for treating pulmonary hypertension. It expects the financing to support the ongoing clinical development and evaluation of the ultrasound-based device. Asabys Partners led the round through its new fund, Sabadell Asabys II. Thuja […]
Cordis names former Spectranetics CEO as executive chair
Interventional vascular tech company Cordis today announced that board member Scott Drake will be the new executive chair of its board of directors. Drake succeeds Duke Rohlen, who served as executive chair since Hellman & Friedman and KKR acquired the company from Cardinal Health in 2021. Rohlen will stay on the company’s board of directors […]
Synchron completes patient enrollment in brain-computer interface trial
Synchron announced today that it completed patient enrollment in the COMMAND clinical trial for its brain-computer interface (BCI). The U.S.-based trial operating under FDA investigational device exemption (IDE) enrolled six patients in total. Synchron says it’s the first IDE awarded by the FDA to assess a permanently implanted BCI. The early feasibility study assesses safety […]